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Abstract
Purpose To estimate airway tapering in control subjects and to assess the usability of tapering as a bronchiectasis biomarker in
paediatric populations.
Methods Airway tapering values were semi-automatically quantified in 156 children with control CTs collected in the Normal
Chest CT Study Group. Airway tapering as a biomarker for bronchiectasis was assessed on spirometer-guided inspiratory CTs
from 12 patients with bronchiectasis and 12 age- and sex-matched controls. Semi-automatic image analysis software was used to
quantify intra-branch tapering (reduction in airway diameter along the branch), inter-branch tapering (reduction in airway
diameter before and after bifurcation) and airway-artery ratios on chest CTs. Biomarkers were further stratified in small, medium
and large airways based on three equal groups of the accompanying vessel size.
Results Control subjects showed intra-branch tapering of 1% and inter-branch tapering of 24–39%. Subjects with bronchiectasis
showed significantly reduced intra-branch of 0.8% and inter-branch tapering of 19–32% and increased airway–artery ratios
compared with controls (p < 0.01). Tapering measurements were significantly different between diseased and controls across all
airway sizes. Difference in airway–artery ratio was only significant in small airways.
Conclusion Paediatric normal values for airway tapering were established in control subjects. Tapering showed to be a promising
biomarker for bronchiectasis as subjects with bronchiectasis show significantly less airway tapering across all airway sizes
compared with controls. Detecting less tapering in larger airways could potentially lead to earlier diagnosis of bronchiectasis.
Additionally, compared with the conventional airway–artery ratio, this novel biomarker has the advantage that it does not require
pairing with pulmonary arteries.
Key Points
• Tapering is a promising objective image biomarker for bronchiectasis that can be extracted semi-automatically and has good
correlation with validated visual scoring methods.
• Less airway tapering was observed in patients with bronchiectasis and can be observed sensitively throughout the bronchial
tree, even in the more central airways.
• Tapering values seemed to be less influenced by variety in scanning protocols and lung volume making it a more robust
biomarker for bronchiectasis detection.
Keywords Bronchiectasis . Bronchi . Image interpretation computer-assisted . Imaging three-dimensional . Multidetector
computed tomography
Electronic supplementary material The online version of this article
(https://doi.org/10.1007/s00330-019-06606-w) contains supplementary
material, which is available to authorized users.
* Marleen de Bruijne
marleen.debruijne@erasmusmc.nl
1 Department of Paediatric Pulmonology and Allergology, Erasmus
MC – Sophia Children’s Hospital, Rotterdam, The Netherlands
2 Department of Radiology and Nuclear Medicine, Erasmus MC,
Rotterdam, The Netherlands
3 Biomedical ImagingGroupRotterdam, Department of Radiology and
Nuclear Medicine, Erasmus MC, room NA-2611, PO Box 2040,
3000 CA Rotterdam, The Netherlands
4 Department of Computer Science, University of Copenhagen,
Copenhagen, Denmark
European Radiology
https://doi.org/10.1007/s00330-019-06606-w
Introduction
Airway tapering is the reduction in diameter from the central
to the peripheral airways. In healthy subjects, the diameter of
an airway branch is similar to that of the accompanying artery
[1] and there is subtle but progressive diameter reduction
along each branch named intra-branch tapering [2]. In addi-
tion, the diameter of the airway branch is reduced compared
with the airway branch before bifurcation [3] also referred to
as inter-branch tapering.
Bronchiectasis is a structural change that can occur in dis-
eased airways of patients with cystic fibrosis (CF) [4, 5],
chronic obstructive pulmonary disease (COPD) [4], common
variable immunodeficiency (CVID) [6] and tuberculosis [2].
Bronchiectasis is defined as an irreversible dilation of the air-
ways accompanied with lack of tapering [2]. Chest computed
tomography (CT) is currently the most sensitive imaging tool
to detect bronchiectasis [7, 8] and is a sensitive outcome mea-
sure in CF for both clinical and research purposes [9–11].
There are three ways to diagnose bronchiectasis on CT.
Firstly, the diameter of the airway exceeds that of the accom-
panying artery, also quantified by computing the airway–
artery ratio (AA ratio) [12–16]. Secondly, visibility of airways
within 1 cm of the costal pleura or the mediastinal pleura
indicates bronchiectasis. Lastly, lack of tapering, defined as
an unchanged airway diameter for 2 cm after branching [2], is
a recognised criterion for diagnosing bronchiectasis [17].
Tapering has been included in various semi-quantitative
visual scoring systems for bronchiectasis. Nevertheless, only
a few scoring systems and studies have included a tapering
quantification to assess bronchiectasis in the paediatric popu-
lation [14, 18].
In this study, we used newly developed state-of-the-art au-
tomated image analysis software to (1) estimate control values
for intra-branch and inter-branch tapering in peadiatric pa-
tients with a normal chest CT; and (2) assess differences in
airway tapering between control patients and patients with
bronchiectasis, comparing the diagnostic value of airway ta-
pering and AA ratios in children with early to moderate lung
disease.We hypothesise that lack of tapering can be quantified
using automatic analysis in order to detect bronchiectasis in
early to moderate lung disease. Lack of tapering could poten-
tially be detected in the larger airways when a change in AA
ratio is not yet prominent. An abnormally dilated peripheral
airway might coincide with reduced tapering solely present in
the dilated airway branch, in the airway branches immediately
before the dilated branch or all the way up to the central air-
ways (Fig. 1).
Materials and methods
This study was approved by institutional review board (MEC-
2014-254 and MEC-2011-494). Written informed consent
was waived for all subjects due to the retrospective nature of
this study.
Study population
In this study, a total of 180 CTs from three datasets were used.
Airway tapering values were obtained in a subset of three
participating centres from the Normal Chest CT Study Group.
This dataset was developed to establish chest CT reference
values in children and was reported in a previous publication
[19]. In summary, retrospectively collected CTs were made for
various clinical indications of paediatric subjects aged 0 to 18
years old. CTs considered to be normal by the reporting radi-
ologist from the initial ten international centres were included
after a reassessment by an independent radiologist (C.Y.). All
CTs were deidentified and anonymised. In this study, 156 CTs
from three centres were included and further referred to as the
NormalCT dataset. CTs were acquired during free breathing
for non-cooperative young children or a voluntary breath-hold
in older subjects. Forty-two of the 156 subjects were scanned
with contrast.
The Matched-Bronchiectasis and Matched-Controls
datasets were used to assess differences in airway tapering
between patients with bronchiectasis and control subjects.
The Matched-Bronchiectasis and Matched-Controls datasets
have been initially used to study changes in AA ratios and
Fig. 1 a Bronchial tree with
tapering similar to its
accompanying artery, showing
approximately constant airway–
artery ratio. b Bronchial tree with
reduced airway tapering uniform-
ly distributed across the entire
bronchial tree, showing an in-
creased airway–artery ratio more
pronounced in the more peripher-
al airways
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were reported separately [1, 20, 21]. In summary, the
Matched-Bronchiectasis consisted of spirometer-guided inspi-
ratory chest CTs of 12 patients between 8 and 16 years old (11
CF and 1 non-CF bronchiectatic patient with CVID; 7 fe-
males) with reported signs of bronchiectasis. Matched-
Controls consisted of 12 spirometer-guided inspiratory scans
of age- and sex-matched controls. The control patients were
referred to the Erasmus MC-Sophia Children’s Hospital for a
chest CT for several clinical indications and their CT was
assessed as normal by the Erasmus MC radiologists and an
independent radiologist (C.Y.). Both groups were treated at
the Erasmus MC-Sophia Children’s Hospital (electronic sup-
plementary material (ESM) for scanning details).
Visual scores were obtained for all CTs from the matched
datasets using the CF-CT scoring module as reported previ-
ously [1, 14]. In short, the five lung lobes and lingula were
evaluated for severity and extent of bronchiectasis, airway
wall thickening and mucous plugging on inspiratory CT.
Only bronchiectasis sub-score is reported in the current study.
Automatic quantification of airways and arteries
In-house developed software (written in C++ and MATLAB)
was used to measure AA ratio and airway tapering for all
extracted airways. This previously validated method [21] au-
tomatically extracts the bronchial tree and arteries using a
classifier approach [22]. It obtains diameter measurements
every 0.5 mm via a graph-based method [23], and pairs airway
and artery branches according to their proximity and similarity
in size and orientation. Because of the large variations in
inspiration level and scanning protocols in the NormalCT
dataset, the automatic extraction of initial airway centrelines
was replaced by manually drawn airway centrelines (detailed
in ESM). Airway centrelines in the NormalCT dataset were
drawn manually as an initialisation after which the segmenta-
tion was done automatically. Therefore, the segmentation was
fully automatic but the extraction was not. Variations in lung
size due to differences in subject size, sex and inspiration level
were adjusted for. All measurements were isotropically
rescaled, using the cubic root of the lung volume measured
on CT, to correspond to 4 L, which is the approximate mea-
sured mean lung volume of all subjects.
For each airway artery pair, the following measurements
were obtained for the inner and outer airway diameters
separately:
Airway–artery ratio Obtained as the ratio between the airway
diameter and its accompanying artery diameter. AA ratio was
determined along the branchwhere the outer airway and artery
diameters were most similar in terms of size, orientation and
position.
Intra-branch taperingA line (y = mx + n, wherem is the slope
of the line and n the y-intercept) was fitted to the diameters
measured along the airway branch, using the bi-square
weights method (Fig. 2). Intra-branch tapering was obtained
as intraBT = −mn  100, demonstrating the percentage reduc-
tion in airway diameter per millimetre along the centreline.
Intra-branch tapering (intraBT) of 2 means that the airway
diameter is reduced by 2% per millimetre.
Fig. 2 Diameter measurements
along an airway branch in a
control subject showing
progressive reduction of diameter
due to intra-branch tapering. Left
(0) corresponds to the proximal
end just after bifurcation and right
(19) to the distal end just before
the next bifurcation
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Inter-branch tapering Inter-branch tapering was obtained as
interBT = dp−ddp  100, where d is the average diameter of the
analysed airway branch and dp is the average diameter of the
parent airway (the airway branch one generation previously).
Inter-branch tapering (interBT) of 20 would indicate that the
airway branch is 20% smaller than that before bifurcation.
Tapering was measured for all airways, but for ease of
comparison with the AA ratios, only measurements of airways
paired with an artery are reported, unless stated otherwise.
Image biomarkers for bronchiectasis quantification
Per-subject median AA ratio, interBTand intraBTof inner and
outer a i rway were compared between Matched-
Bronchiectasis and Matched-Control datasets to assess their
value as biomarkers for bronchiectasis.
Previous studies showed that diseased subjects showed
more visible peripheral airways on CT compared with control
subjects [1, 24]. Since peripheral airways in diseased subjects
are larger and may have more clearly defined walls than in
controls, peripheral airways that would be too small to be
observed if healthy become large enough to be visible on
CT. This leads to a selection bias where more peripheral air-
ways are visible in patients with airway disease compared
with controls, influencing biomarker differences between con-
trols and diseased. Therefore, differences between groups
were also analysed by airway size. All airways from the
Matched-Controls dataset were divided into three equally
sized groups according to the diameter of their accompanying
artery. Airways with an accompanying artery smaller than
3.08 mm, between 3.08 and 4.23 mm and greater than
4.23 mm were considered airways with small, medium and
large arteries respectively. These thresholds were also applied
to the Matched-Bronchiectasis and NormalCT datasets.
Airway generation was acquired automatically for each
measurement, but was not used for grouping due to the incon-
sistency of the airway sizes of the upper segmental (starting at
generation 3 to 4) and the lower segmental bronchi (starting at
generation 4 to 7) [1].
Stability of biomarkers under varying scanning
conditions
Extracted biomarkers were investigated to variations in scan-
ning conditions. Biomarkers extracted from the single-centre
spirometry-controlled inspiration CTs from the Matched-
Control dataset were compared with the biomarkers obtained
in the CTs from the multicentre NormalCT group, which are
of CTs with a large variation in inspiration level and scanning
protocols.
Statistical analysis
In order to exclude outliers and segmentation errors, we per-
formed robust statistics using median and inter-quartile ranges
(IQRs). The median was used to summarise all airway–artery
measurements per subject and the median and IQR were re-
ported for each population. Per subject median values of each
airway size group were compared between all datasets using
the Mann–Whitney U test. Spearman correlation coefficient
was performed to assess correlations. P values < 0.05 were
considered significant.
Results
Demographics of all subjects in this study are presented in
Table 1. A total of 22,275 airway branches were semi-
automatically and 153,238 artery branches were automatically
extracted. Of these, 13,987 airway–artery pairs were detected
Table 1 Demographics and
visual scores of the three datasets Matched-
Bronchiectasis
Matched-Controls NormalCT
Lung volume during CT
acquisition
Spirometer-guided
inspiratory CT
Spirometer-guided
inspiratory CT
Free breathing and voluntary
breath hold
n 12 12 156
Age at CT (years old) 10.6 [9.7, 11.7] 13.9 [8.7, 15.0] 10.7 [5.5, 15.0]
Sex 7 males; 5 females 7 males; 5 females 101 males; 54 females
Height (cm) 143.7 [137.4, 146.2] 149 [136.6, 170.9] Not available
Weight (kg) 34.3 [29.5, 40.8] 40.1 [28.6, 65.8] Not available
BMI 17.2 [15.6, 18.5] 18.1 [15.9, 20.2] Not available
CFCT BE (%) 7.5 [1.4, 13.3] 0.0 [0.0, 0.7]* Not available
The demographics and visual scores are expressed as median [lower quantile, upper quartile]
CFCT BE stands for the visual sub-scoring of bronchiectasis
*Statistically significant differences with Matched-Bronchiectasis (p value < 0.05)
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and their AA ratio and tapering measurements were measured
automatically for the purpose of this study.
Control values
In the NormalCT dataset, median intraBT of the inner and
intraBTof the outer airways were 1.16% and 0.94%, respective-
ly, expressed as a percentage reduction in airway diameter per
millimetre. Median interBTof the inner and interBTof the outer
airways were 38.54% and 23.75%, respectively, expressed as the
percentage diameter reduction for each airway branching.
Stratified by artery size for small, medium and large, intraBT
of the inner airway were 1.33%, 1.33% and 0.95%; intraBT of
the outer airway were 0.94%, 1.00% and 0.93%; interBTof the
inner airwaywere 42.02%, 39.35% and 34.20%; and interBTof
the outer airwaywere 25.39%, 25.08% and 22.08%, respective-
ly (ESM e-Tables 2–4 for details).
Image biomarkers for bronchiectasis quantification
Matched-Bronchiectasis did not show a significant difference in
inner AA ratio compared with Matched-Controls (p < 0.470).
Outer AA ratio was significantly increased (p < 0.022) in pa-
tients with bronchiectasis compared with that in controls.
All inter-branch and intra-branch tapering values were sig-
nificantly lower (p < 0.003) in patients with bronchiectasis
compared with those in the matched controls.
Figure 3 shows the distribution of each image biomarker,
with the descriptive statistics detailed in Table 2.
Since tapering measurements do not require a paired artery,
tapering measurements including all 22,275 airways (13,987 AA
pairs and 8288 airways without a paired artery) are also reported
in ESM e-Table 5. No significant differences in tapering were
observed between measurements obtained from all airways ver-
sus measurements using only paired airways and arteries.
Image biomarkers for bronchiectasis quantification,
stratified by airway size
Figure 4 shows the image biomarker distribution in the three
datasets divided into airways with small, medium and large
arteries (ESM e-Tables 2 to 4 for detailed values).
Inner and outer AA ratios were not significantly different
between Matched-Bronchiectasis and Matched-Controls for
any airway size group. In contrast, intraBT and interBT of the
inner airway, and interBTof the outer airway were significantly
less in the Matched-Bronchiectasis compared with those in the
Matched-Controls for all airway size groups. IntraBT of the
outer airway trended to be less in the Matched-Bronchiectasis
group compared with that in the Matched-Controls for all air-
way size groups, but this finding was not significant (p < 0.08).
Stability of biomarkers under varying scanning
conditions
When analysing all airways, the AA ratio and intraBT of the
inner airways were significantly different between the control
groups with and without lung volume control (Fig. 3 and
Table 2).
When airways were stratified by size, all AA ratios and
intraBT for inner airways of the small artery sizes were sig-
nificantly different between the spirometry-controlled subjects
of the Matched-Controls and the free-breathing subjects of the
NormalCT dataset (Fig. 4, and ESM e-Tables 2–4).
Fig. 3 Distributions of airway–
artery ratio, intra-branch tapering
and inter-branch tapering for each
dataset. BE, Matched-
Bronchiectasis; C, Matched-
Controls; N, NormalCT. Note that
bronchiectatic subjects show sig-
nificantly lower airway tapering
than controls
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Correlations with visual scoring
The median (IQRs) of the visual bronchiectasis scores were
7.45 (1.40–13.38) for the Matched-Bronchiectasis and 0.00
(0.00–0.70) for the Matched-Controls. Per-subject median
values correlated well with CF-CT bronchiectasis sub-score
for all biomarkers (Table 3). Only interBT and intraBT of the
inner airways showed a strong and significant correlation with
CF-CT bronchiectasis across all airway size groups.
Discussion
Lack of airway tapering or less tapering has long been known
to be an important criterion to define bronchiectasis in clinical
practice [25]. Recent developments in computer algorithms to
analyse chest CTs result in more insight into tapering as a
biomarker. In this study, semi-automated intra- and inter-
branch airway tapering values were quantified in a cohort of
normal paediatric chest CTs for control values and were com-
pared with tapering values of children with bronchiectasis.
The first important finding of this study is that control
tapering values were established on CTs of paediatric patients.
No previous reported values exist for the intra-branch tapering
of the inner or outer airway or the inter-branch tapering of the
outer airway. Inter-branch tapering of the inner airway (also
known as homothety ratio) has previously been reported in
bronchial casts [3] and CT scans [26, 27] of healthy adults
and ranged between 21 and 29%. These values are lower than
the median inter-branch tapering of the inner airway of 38.5%
reported in this study for the NormalCT dataset. A possible
explanation for this difference is that the automatic diameter
measurements are consistently lower than measured by hu-
man observers, leading to a higher tapering value [21]. A
constant, absolute reduction in diameter along the airway tree
would result in higher tapering values. Another explanation
Fig. 4 Distributions of airway–
artery ratio, inter-branch tapering
and intra-branch tapering for
small, medium and large airways,
grouped by dataset. BE,Matched-
Bronchiectasis; C, Matched-
Controls; N, NormalCT. Some
outliers in the NormalCT that fell
outside the axes range have been
removed from this plot for clarity.
Note that changes in airway ta-
pering are observed across all air-
way sizes between bronchiectatic
subjects and controls
Table 2 Summary of AA ratio and tapering biomarkers and comparison between the three datasets
Matched-
Bronchiectasis
Matched-Controls NormalCT BE vs C C vs N
AA ratio Inner 0.62 [0.51, 0.68] 0.59 [0.52, 0.63] 0.41 [0.37, 0.46] 0.4705 0.0000
AA ratio Outer 1.31 [1.18, 1.36] 1.16 [1.07, 1.25] 1.14 [1.05, 1.23] 0.0226 0.5173
Intra-branch tapering Inner 0.89 [0.72, 1.14] 1.56 [1.33, 1.67] 1.16 [0.97, 1.42] 0.0003 0.0049
Intra-branch tapering Outer 0.65 [0.54, 0.77] 0.97 [0.89, 1.15] 0.94 [0.72, 1.17] 0.0029 0.6757
Inter-branch tapering Inner 32.28 [28.19, 34.75] 38.54 [36.26, 40.73] 38.54 [35.12, 41.43] 0.0024 0.9778
Inter-branch tapering Outer 19.31 [17.86, 20.65] 23.23 [22.45, 25.08] 23.75 [20.41, 26.75] 0.0005 0.9087
The median and inter-quartile range are shown for the image biomarkers extracted from all airway–artery pairs. p values of theMann–WhitneyU test are
shown for each image biomarker: between the Matched-Bronchiectasis (BE) andMatched-Controls (C); and betweenMatched-Controls and NormalCT
(N). Significant values (p < 0.05) are italicised
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could be that the present study analysed paediatric subjects,
whereas previous reporting showed tapering values for adults.
The second important finding is that tapering measures were
an independent biomarker reflecting airway disease.
Significantly less intra-branch and inter-branch taperingwas seen
in the 12 patients with bronchiectasis in comparisonwith that in a
matched control group, for both inner and outer airway diame-
ters. This is in concordance with the visually assessed lack of
tapering in bronchiectatic airways as previously described [2, 14,
17]. In addition, tapering measurements of diseased airways cor-
related well with visual scores. Previous studies measuring air-
way tapering in bronchiectatic subjects focused solely on inter-
branch tapering of the inner airway and are in concordance with
this study. Odry et al found a correlation between tapering of the
inner airway and visual inspection of bronchiectasis in one
healthy and 8 diseased subjects [28]. Weinheimer et al found a
correlation between lobar inner airway taper indices and visual
scores in 144 CTs of paediatric CF patients [18].
The third important finding is that airways taper significantly
less across all airway sizes in patients with bronchiectasis com-
pared with that in the matched controls. In contrast, the AA ratio
was only significantly increased in the group of airways with
arteries of patients with bronchiectasis. These findings suggest
that tapering has potential to add information to our current un-
derstanding of the pathophysiology of diffuse airways disease.
Abnormally dilated peripheral airway might coincide with less
tapering in the airway branches immediately before the dilated
branch or all the way up to the central airways (Fig. 1). Our study
showed less airway tapering to be not only present in the dilated
branch but also noticeably less tapered in the more central air-
ways. As such, abnormal structural changes related to bronchi-
ectasis in the smaller airways are present in larger airways as well
and can be detected using our automated analysis. Differences in
airway tapering observed in medium and large airways (grouped
by accompanying artery size) indicate that differences between
groups are not driven by a selection bias, where abnormally
dilated airways are more predominant in the airway group with
small arteries of diseased subjects. From a clinical point of view,
detecting structural changes in the larger airways couldmean that
airway disease progression can be measured with greater preci-
sion, in an earlier stage, or on CT scans with lower radiation
exposure such as the CT protocols used in infants [29]. This is
important for lung diseases that are affected by bronchiectasis,
since bronchiectasis is an irreversible condition andwhen present
treatment needs to be initiated to prevent further progression [30].
The final important finding of this study is that outer airway
measures seem to be affected less by inspiration level during CT
acquisition. Significant differences inAA ratio and intraBTof the
inner airway between the spirometry-controlled inspiration scans
of the Matched-Controls and the CTs acquired without lung vol-
ume control of the NormalCT dataset were observed, while none
of the outer airway measurements differed significantly between
control groups. This is in agreement with previous studies
reporting the outer airway diameter to be more robust to varia-
tions in lung volume and scanning protocol [1].
This study has several limitations. First, the number of subjects
with bronchiectasis analysed is small and consisted of 11 patients
with CF and one patient with CVID. However, nearly 14,000
airway–artery pairs were analysed, providing sufficiently accurate
measures to observe significant differences and creating prelimi-
nary insights into tapering indices in children. In addition, both
diseases lead to recurrent infections inducing structural airway
abnormalities including bronchiectasis. Secondly, the control pa-
tients might have been affected by disease. All control subjects
were reported by two independent radiologists who discarded any
subject with signs of lung abnormalities or bronchiectasis on CT,
but we cannot exclude that subtle signs of lung abnormality may
have been missed. In this case, the actual difference between
bronchiectatic and control groups would have been larger than
perceived in this study. Additionally, the scans of the subjects in
Table 3 Correlation of the image
biomarkers with visual scoring Inter-branch tapering
All Small Medium Large
Inner airway − 0.67 (0.0004) − 0.57 (0.0042) − 0.49 (0.0175) − 0.52 (0.0094)
Outer airway − 0.65 (0.0005) − 0.51 (0.0139) − 0.31 (0.1465) − 0.53 (0.0076)
Intra-branch tapering
All Small Medium Large
Inner airway − 0.75 (0.0000) − 0.70 (0.0002) − 0.65 (0.0009) − 0.60 (0.0021)
Outer airway − 0.56 (0.0046) − 0.35 (0.1041) − 0.50 (0.0144) − 0.44 (0.0334)
AA ratio
All Small Medium Large
Inner airway 0.53 (0.0083) 0.64 (0.0011) 0.28 (0.1904) 0.14 (0.5142)
Outer airway 0.75 (0.0000) 0.73 (0.0001) 0.46 (0.0272) 0.24 (0.2631)
Spearman correlation coefficient was used between visual scores of bronchiectasis and each image biomarker was
stratified by size of all the patients of the Matched-Bronchiectasis and Matched-Control datasets. Significant
values (p < 0.05) are italicised
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the NormalCT datasets are more heterogeneous as the subjects
have a wider spread age ranges, CT acquisitions were made dur-
ing different lung inspiration levels and 27% of the NormalCT
dataset were CT scans with contrast and different reconstruction
kernels were used. We therefore adjusted for the different lung
sizes and inspiration levels. The difference inCTacquisitions such
as contrast and kernels would have likely influenced the measure-
ments of the airways and arteries [31]. However, we believe ta-
pering measures should have been affected minimally as it esti-
mates the percentage reduction along the airway. Third, median
values within a subject were analysed, and therefore pathological
changes that affect only a minority of airways might have been
missed. Fourth, some discrepancy was found in the results of this
study and previous work using the same dataset. Significant dif-
ferences in outer AA ratio between patients with bronchiectasis
and control patients were found when airways were stratified by
generation [1]. This differs from the current study, where no sig-
nificant differences in outer AA ratio were found between dis-
eased and controls when airways were stratified by size. This
discrepancy might be explained because the median outer AA
ratio of each airway group and the subject was used to assess
differences between diseased and controls, while the previous
study included all AA ratio measurements in a more complex
mixed-models analysis, leading to higher statistical power.
In conclusion, we reported tapering control values showed
that lack of tapering associated with bronchiectasis occurs nearly
uniformly across all airway sizes, and that airway tapering chang-
es can be readily observed in larger airways while changes in AA
ratios cannot. Acquiring tapering measures offers two important
advantages over acquiring AA ratios. First, tapering measure-
ments do not require extraction and quantification of arteries,
pairing airways with arteries or airway generation labelling.
These steps are all likely to introduce errors in an automated
system. Second, and more importantly, AA ratios assume that
artery size is not affected by disease. This assumption might not
always hold, e.g. patients with pulmonary hypertension, COPD
[32] or smokers have shown to have a reduced diameter of the
pulmonary arteries, leading to an increased AA ratio [33].
Tapering is a promising biomarker for lung diseases that involve
the airways. The clinical significance of tapering should be in-
vestigated in more patients and in other lung diseases for its
propitious potential.
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